indibulin has been researched along with Cancer of Head in 1 studies
indibulin: Tubulin Modulator/Antineoplastic Agent; structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colley, HE | 1 |
| Muthana, M | 1 |
| Danson, SJ | 1 |
| Jackson, LV | 1 |
| Brett, ML | 1 |
| Harrison, J | 1 |
| Coole, SF | 1 |
| Mason, DP | 1 |
| Jennings, LR | 1 |
| Wong, M | 1 |
| Tulasi, V | 1 |
| Norman, D | 1 |
| Lockey, PM | 1 |
| Williams, L | 1 |
| Dossetter, AG | 1 |
| Griffen, EJ | 1 |
| Thompson, MJ | 1 |
1 other study available for indibulin and Cancer of Head
| Article | Year |
|---|---|
An Orally Bioavailable, Indole-3-glyoxylamide Based Series of Tubulin Polymerization Inhibitors Showing Tumor Growth Inhibition in a Mouse Xenograft Model of Head and Neck Cancer.
Topics: Animals; Antineoplastic Agents; Caco-2 Cells; Cell Proliferation; Drug Screening Assays, Antitumor; | 2015 |